🇺🇸 FDA
Patent

US 7507538

Human papilloma virus immunoreactive peptides

granted A61KA61K2039/57A61K2039/6006

Quick answer

US patent 7507538 (Human papilloma virus immunoreactive peptides) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Mar 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Mar 24 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K2039/57, A61K2039/6006, A61K39/00, A61P